Catch up on the top radiology content of the past week.
|Articles|January 21, 1998
PSS begins sales of BreastAlert
Equipment distributor Physician Sales & Service of Jacksonville, FL, has begun selling BreastAlert Differential Temperature Sensor, a device that assists in the early detection of breast cancer by discerning differences in temperature between breast
Advertisement
Equipment distributor Physician Sales & Service of Jacksonville, FL, has begun selling BreastAlert Differential Temperature Sensor, a device that assists in the early detection of breast cancer by discerning differences in temperature between breast tissue. HumaScan, the company with marketing rights to BreastAlert, began shipping the first BreastAlert sensors to PSS distribution facilities in late December. BreastAlert was developed by Scantek Medical of Denville, NJ, which granted U.S. and Canadian rights to the product to HumaScan of Cranford, NJ.
The device consists of heat-sensitive pads that are placed on each breast to measure breast tissue temperature, which can be higher in cancerous tissue due to the metabolic activity of early-stage tumors, HumaScan claims. A difference of 2F between mirror-image segments of the breasts indicates that pathology may be present and that a patient should be sent on for mammography screening. HumaScan hopes the product will prove useful in women under age 40, a population that is not recommended for mammography screening.
Advertisement
Related to this article
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Diagnostic Imaging's Weekly Scan: September 27 — October 3
2
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1
3
Raising Questions on the Prognostic Value of Fractional Flow Reserve from CCTA
4
FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection
5